2376

KOE:237690

ST Pharm Co.,Ltd.

  • Stock

KRW

Last Close

79,000.00

02/05 06:30

Market Cap

1.84T

Beta: 0.91

Volume Today

42.46K

Avg: 100.78K

PE Ratio

66.09

PFCF: −31.70

Dividend Yield

0.80%

Payout:52.80%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
138.05B
-
200.36B
45.13%
202.80B
1.22%
97.74B
51.81%
93.26B
4.59%
124.11B
33.08%
165.64B
33.47%
249.32B
50.52%
284.99B
14.31%
273.75B
3.94%
cost of revenue
86.93B
-
107.56B
23.73%
123.18B
14.53%
95.19B
22.72%
96.05B
0.90%
107.55B
11.97%
110.33B
2.59%
162.14B
46.95%
178.36B
10.01%
177.59B
0.43%
gross profit
51.12B
-
92.81B
81.54%
79.62B
14.21%
2.55B
96.80%
-2.80B
209.79%
16.56B
692.36%
55.31B
233.98%
87.18B
57.63%
106.63B
22.31%
96.16B
9.82%
selling and marketing expenses
2.27B
-
2.31B
2.03%
2.21B
4.46%
2.99B
35.19%
1.95B
34.79%
1.95B
0.12%
2.82B
44.40%
3.18B
12.63%
5.10B
-
general and administrative expenses
126.99M
-
122.78M
3.31%
168.42M
37.17%
192.99M
14.59%
255.88M
32.59%
372.51M
45.58%
410.15M
10.10%
771.35M
88.07%
5.98B
-
selling general and administrative expenses
6.20B
-
6.47B
4.36%
7.88B
21.69%
9.10B
15.45%
9.49B
4.36%
22.97B
141.92%
27.89B
21.46%
37.66B
35.03%
44.75B
18.81%
11.08B
75.25%
research and development expenses
10.34B
-
8.58B
17.02%
9.66B
12.59%
8.77B
9.21%
14.41B
64.29%
12.41B
13.90%
18.22B
46.80%
26.31B
44.39%
30.85B
17.25%
22.11B
28.32%
other expenses
-250.67B
-
35.29B
114.08%
cost and expenses
98.24B
-
119.26B
21.39%
144.76B
21.39%
112.65B
22.18%
119.96B
6.49%
142.93B
19.14%
160.16B
12.06%
228.45B
42.64%
253.96B
11.16%
246.06B
3.11%
operating expenses
11.31B
-
11.70B
3.44%
21.57B
84.40%
17.46B
19.07%
23.91B
36.93%
35.38B
47.98%
49.83B
40.85%
66.31B
33.08%
75.59B
14.00%
68.47B
9.42%
interest expense
78.87M
-
644.58M
717.27%
6.11B
-
7.74B
26.74%
ebitda
40.63B
-
88.37B
117.48%
73.40B
16.94%
-6.42B
108.74%
-15.52B
141.84%
-4.75B
69.40%
19.99B
520.96%
35.45B
77.33%
54.06B
52.50%
76.07B
40.70%
operating income
34.47B
-
77.58B
125.06%
61.83B
20.30%
-15.65B
125.30%
-26.70B
70.67%
-18.82B
29.53%
5.58B
129.64%
17.85B
220.06%
31.04B
73.86%
27.69B
10.77%
depreciation and amortization
6.16B
-
10.79B
75.06%
11.57B
7.26%
9.23B
20.22%
11.19B
21.19%
14.07B
25.77%
14.41B
2.46%
17.60B
22.10%
23.03B
30.83%
25.58B
11.10%
total other income expenses net
1.13B
-
2.91B
157.55%
-2.59B
188.93%
2.26B
187.09%
1.73B
23.27%
1.99B
15.11%
-4.32B
316.74%
1.39B
132.09%
-7.68B
654.37%
15.05B
295.98%
income before tax
35.60B
-
80.50B
126.10%
59.24B
26.40%
-13.39B
122.60%
-24.97B
86.49%
-16.82B
32.63%
1.26B
107.49%
19.24B
1,426.50%
23.35B
21.40%
42.75B
83.04%
income tax expense
10.41B
-
19.07B
83.13%
14.25B
25.29%
4.12B
71.06%
-6.44B
256.29%
-3.67B
43.05%
2.12B
157.69%
1.72B
18.70%
5.83B
238.74%
10.28B
76.35%
net income
25.19B
-
61.43B
143.86%
45.00B
26.75%
-9.27B
120.60%
-18.53B
99.92%
-12.15B
34.44%
3.31B
127.27%
18.00B
443.46%
19.58B
8.78%
34.71B
77.27%
weighted average shs out
12.53M
-
15.91M
27.01%
18.58M
16.80%
18.65M
0.35%
18.66M
0.04%
18.66M
0%
18.71M
0.30%
18.81M
0.51%
18.81M
0.00%
19.50M
3.70%
weighted average shs out dil
12.53M
-
16.35M
30.50%
18.66M
14.18%
18.66M
0.04%
18.66M
0%
18.66M
0%
18.66M
0.05%
18.81M
0.77%
18.81M
0%
19.50M
3.70%
eps
2.01K
-
3.76K
86.87%
2.41K
35.84%
-497
120.61%
-993.18
99.84%
-651.11
34.44%
177
127.18%
957
440.68%
1.04K
8.78%
1.98K
89.85%
epsdiluted
2.01K
-
3.76K
86.87%
2.41K
35.84%
-496.78
120.60%
-993.18
99.92%
-651.11
34.44%
177.45
127.25%
957
439.31%
1.04K
8.78%
1.98K
89.85%

All numbers in KRW (except ratios and percentages)